Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INTELLIGENT BIO SOLUTIONS INC. Director's Dealing 2021

May 22, 2021

35195_dirs_2021-05-21_2e67ad1a-ed1a-469d-97f1-f424a90eec0d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GBS Inc. (GBS)
CIK: 0001725430
Period of Report: 2021-05-19

Reporting Person: Sakiris Spiro Kevin (Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-05-19 Common Stock P 10000 $3.066 Acquired 16258 Direct